share_log

Those Who Invested in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Are up 78%

Those Who Invested in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Are up 78%

那些五年前投資IDEXX Laboratories(納斯達克:IDXX)的人現在的收益增長了78%。
Simply Wall St ·  09/07 09:15

The simplest way to invest in stocks is to buy exchange traded funds. But the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the IDEXX Laboratories, Inc. (NASDAQ:IDXX) share price is 78% higher than it was five years ago, which is more than the market average. The 1.4% share price rise over the last year is decent, but not great.

投資股票的最簡單方法是購買交易所交易基金。但事實是,如果你以合適的價格購買高質量的企業,你可以獲得可觀的收益。例如,IDEXX實驗室有限公司(納斯達克股票代碼:IDXX)的股價比五年前高出78%,高於市場平均水平。去年股價上漲了1.4%,雖然不錯,但並不理想。

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

現在也值得一看公司的基本面,因爲這將有助於我們確定長期股東回報是否與基礎業務的表現相匹配。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。

Over half a decade, IDEXX Laboratories managed to grow its earnings per share at 17% a year. This EPS growth is higher than the 12% average annual increase in the share price. Therefore, it seems the market has become relatively pessimistic about the company.

在過去的五年中,IDEXX實驗室設法將其每股收益增長到每年17%。每股收益的增長高於股價平均年增長12%。因此,市場似乎對該公司變得相對悲觀。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖描述了 EPS 隨着時間的推移是如何變化的(點擊圖片可以看到確切的值)。

big
NasdaqGS:IDXX Earnings Per Share Growth September 7th 2024
納斯達克GS:IDXX 每股收益增長 2024 年 9 月 7 日

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

在買入或賣出股票之前,我們始終建議仔細研究歷史增長趨勢,可在此處查閱。

A Different Perspective

不同的視角

IDEXX Laboratories provided a TSR of 1.4% over the last twelve months. But that return falls short of the market. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 12% over five years. It may well be that this is a business worth popping on the watching, given the continuing positive reception, over time, from the market. Before spending more time on IDEXX Laboratories it might be wise to click here to see if insiders have been buying or selling shares.

在過去的十二個月中,IDEXX實驗室的股東總回報率爲1.4%。但是這種回報不及市場。這可能是一個好兆頭,表明該公司的長期業績記錄甚至更好,在五年內爲股東提供了12%的年度股東總回報率。鑑於隨着時間的推移,市場持續給予積極的歡迎,這很可能是一項值得關注的業務。在花更多時間在IDEXX Laboratories之前,明智的做法可能是點擊此處查看內部人士是否在買入或賣出股票。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,通過尋找其他地方,你可能會找到一筆不錯的投資。因此,請看一下我們預計收益將增加的這份免費公司名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論